Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fleming

Showing results (781-790 of 862) with videos related to

Pageof 87
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Detection of distant familial relatedness in biobanks for identification of undiagnosed carriers of a Mendelian disease variant: application to Long QT syndromeMegan C Lancaster, Hung-Hsin Chen, M Benjamin Shoemaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancerJ E Krook, J R Jett, T R Fleming, et al.
Cancer Treatment Reports|November 1, 1985
Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomasJ H Edmonson, G W McCormack, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinomaT R Buroker, C G Moertel, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
Journal of the American Chemical Society|March 30, 2022
Synthetic Control of Exciton Dynamics in Bioinspired Cofacial Porphyrin DimersPartha Pratim Roy, Sohang Kundu, Jesús Valdiviezo, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2024
Chlorophyll to zeaxanthin energy transfer in nonphotochemical quenching: An exciton annihilation-free transient absorption studyTsung-Yen Lee, Lam Lam, Dhruv Patel-Tupper, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 13, 2014
Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertensionGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Pageof 87

Showing results (781-790 of 862) with videos related to

Sort By:
Pageof 87
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Detection of distant familial relatedness in biobanks for identification of undiagnosed carriers of a Mendelian disease variant: application to Long QT syndromeMegan C Lancaster, Hung-Hsin Chen, M Benjamin Shoemaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancerJ E Krook, J R Jett, T R Fleming, et al.
Cancer Treatment Reports|November 1, 1985
Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomasJ H Edmonson, G W McCormack, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinomaT R Buroker, C G Moertel, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
Journal of the American Chemical Society|March 30, 2022
Synthetic Control of Exciton Dynamics in Bioinspired Cofacial Porphyrin DimersPartha Pratim Roy, Sohang Kundu, Jesús Valdiviezo, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2024
Chlorophyll to zeaxanthin energy transfer in nonphotochemical quenching: An exciton annihilation-free transient absorption studyTsung-Yen Lee, Lam Lam, Dhruv Patel-Tupper, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 13, 2014
Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertensionGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Pageof 87